Clinical impact of pharmaceutical consultations in patients treated for chronic obstructive pulmonary disease: Study protocol for a randomized controlled trial (BPCObs study).

Hachemi D, Leguelinel-Blache G, Bouvet S, Roux-Marson C, Plouvier N, Kinowski JM, Castelli C, Dubois F

Open source

DOI
10.1016/j.conctc.2023.101249
Published
2024 Feb
Container
Contemporary clinical trials communications
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.conctc.2023.101249,
  title = {Clinical impact of pharmaceutical consultations in patients treated for chronic obstructive pulmonary disease: Study protocol for a randomized controlled trial (BPCObs study).},
  author = {Hachemi D and Leguelinel-Blache G and Bouvet S and Roux-Marson C and Plouvier N and Kinowski JM and Castelli C and Dubois F},
  year = {2024},
  journal = {Contemporary clinical trials communications},
  doi = {10.1016/j.conctc.2023.101249},
  url = {https://doi.org/10.1016/j.conctc.2023.101249}
}

RIS

TY  - JOUR
TI  - Clinical impact of pharmaceutical consultations in patients treated for chronic obstructive pulmonary disease: Study protocol for a randomized controlled trial (BPCObs study).
AU  - Hachemi D
AU  - Leguelinel-Blache G
AU  - Bouvet S
AU  - Roux-Marson C
AU  - Plouvier N
AU  - Kinowski JM
AU  - Castelli C
AU  - Dubois F
PY  - 2024
JO  - Contemporary clinical trials communications
DO  - 10.1016/j.conctc.2023.101249
UR  - https://doi.org/10.1016/j.conctc.2023.101249
ER  - 

APA

D, H., G, L., S, B., C, R., N, P., JM, K., C, C., & F, D. (2024). Clinical impact of pharmaceutical consultations in patients treated for chronic obstructive pulmonary disease: Study protocol for a randomized controlled trial (BPCObs study).. Contemporary clinical trials communications. https://doi.org/10.1016/j.conctc.2023.101249

Source records